Huberman Lab

Dr. Andrew Huberman: How to Beat Depression Naturally

How norepinephrine deficits and inflammation drive major depression; Huberman covers omega-3s, deliberate cold exposure, creatine, and ketamine therapy.

AHAndrew Hubermanhost

Jul 3, 2025·35m·Watch on YouTube ↗

📖 CHAPTERS

1. 1
   0:00 – 7:10

   Defining Major Depression and Core Symptoms

   Huberman introduces major depression, distinguishing it from bipolar depression, and underscores its high prevalence and disability burden. He outlines classic emotional symptoms (sadness, grief, guilt), anhedonia, negative self-confabulation, and vegetative symptoms like disturbed sleep and appetite.

2. 2
   7:10 – 12:00

   Sleep, Cortisol, and the Physiology of Depressive States

   The episode details how depression alters sleep architecture and daily hormone rhythms, particularly cortisol. Huberman explains how early awakenings and a shifted cortisol peak contribute to worsening mood and daytime functioning.

3. 3
   12:00 – 16:10

   Early Antidepressants and the Role of Norepinephrine and Dopamine

   Huberman reviews the discovery of tricyclic antidepressants and MAO inhibitors, which increase norepinephrine, and the later identification of brain pleasure pathways involving dopamine. He correlates these neuromodulators with specific depressive symptoms like lethargy and anhedonia.

4. 4
   16:10 – 22:40

   SSRIs, Serotonin, and Symptom-Specific Neurochemistry

   The discussion moves to SSRIs, how they work at the synapse, and their complex efficacy and side-effect profiles. Huberman then maps norepinephrine, dopamine, and serotonin onto different depressive symptom clusters and explains why treatment is rarely straightforward.

5. 5
   22:40 – 29:30

   Hormones, Stress, and Genetic Vulnerability to Depression

   Huberman examines how thyroid hormone, reproductive hormones, and cortisol influence depressive risk and expression. He emphasizes the interaction of genetic predisposition with chronic stress, especially in those with family histories of major depression.

6. 6
   29:30 – 35:10

   Behavioral Tools: Cold Exposure, Exercise, and Accessing Mood Circuits

   The conversation turns to behavioral interventions that modulate brain chemistry related to depression. Huberman discusses how cold exposure and exercise increase norepinephrine and other neuromodulators, while acknowledging that severe depression can make engaging in these behaviors very difficult.

7. 7
   35:10 – 42:10

   Inflammation, Tryptophan Pathways, and Omega-3 EPA

   Huberman introduces the inflammatory model of depression, outlining how cytokines alter tryptophan metabolism, reducing serotonin and increasing neurotoxic metabolites. He explains how EPA-rich omega‑3s and exercise can modify this pathway and support antidepressant efficacy.

8. 8
   42:10 – 51:20

   Creatine, Ketamine, and Psilocybin as Emerging Treatments

   The episode explores less conventional interventions: creatine for brain energy metabolism, ketamine for dissociative relief from overwhelming grief, and psilocybin-assisted therapy for durable neural and narrative rewiring. Huberman highlights robust clinical data, especially for psilocybin in major depression.

9. 9
   51:20 – 56:20

   Dietary Approaches and Ketogenic Metabolism in Mood Disorders

   Huberman addresses dietary patterns and their relationship to depression, with special attention to the ketogenic diet. He explains how shifting brain fuel to ketones can rebalance excitatory and inhibitory neurotransmission and help particularly in treatment-resistant cases.

10. 10
    56:20

    Recap: Integrated Strategies to Prevent and Treat Depression

    Huberman summarizes the multi-factorial nature of depression and revisits the layered toolbox for managing it. He emphasizes avoiding overstimulation of pleasure systems, tuning the norepinephrine system through healthy challenges, and leveraging anti-inflammatory and neuromodulatory strategies.